A physician–pharmacologist with over eight years of clinical experience in emergency medicine and general practice, I am currently pursuing an MD in Pharmacology with a strong focus on translational and clinical pharmacology. My professional journey reflects a deliberate transition from frontline patient care to systems-level evaluation of medicines, drug safety, and therapeutic decision-making. My core areas of interest include pharmacovigilance, experimental pharmacology, clinical research methodology, and regulatory science. I actively engage in academic research, scientific writing, and conference presentations, with experience in in-vitro and in-silico pharmacological models. With a unique blend of clinical insight and pharmacological expertise, I aspire to contribute to evidence-based innovation and strategic roles within the pharmaceutical industry.

Manori Jayasinghe is a lecturer in pharmacy at the Faculty of Allied Health Sciences, University of Ruhuna, Sri Lanka, and a PhD candidate at the University of Sydney, Australia. Her research focuses on pharmaceutical policy, governance, accountability, and medicine pricing, with an emphasis on affordability, access, and safe use of medicines in low- and middle-income health systems. Her work contributes to interdisciplinary research on health system strengthening and evidence-informed pharmacology and public health policy.

Professor David Wood is a Professor of Clinical Toxicology and Consultant Physician and Guy's and St Thomas' NHS Foundation Trust, King's Health Partners and King's College London, London, UK. He is the Chair of the UK Advisory Council on the Misuse of Drugs.

Dr. María Acelia Marrero Miragaya is a Cuban physician, senior researcher, and Full Professor, specialized in General Surgery and Clinical Trials. She holds a PhD in Medical Sciences and currently serves as President of the Cuban Society of Pharmacology. Dr. Marrero works at the National Coordinating Center for Clinical Trials (CENCEC) and has extensive experience in Phase I–IV clinical trials, particularly in oncology, including monoclonal antibodies and therapeutic vaccines. She has participated in protocol design, study conduction, Good Clinical Practice training, regulatory audits, and academic evaluation committees. Her work includes international scientific publications, conference presentations, and an internationally registered patent, contributing significantly to clinical research and pharmacology in Cuba.